WA DeBacker, J Verbraecken, M Willemen, W Wittesaele, W DeCock and P Van deHeyning
Department of Pulmonary Medicine, University of Antwerp (UIA), Belgium.

Only a limited number of studies dealing with the epidemiology and therapy of central sleep apnea syndrome (CA) are available. The treatment strategies are poorly defined and not well evaluated. The aim of our present study was to treat selected CA patients with low dose acetazolamide (ACET) for a longer time period than has been done before. Previous studies were performed with high dose ACET provoking severe metabolic acidosis, not for more than 1 wk or only in obstructive apnea patients. Referred patients with suspicion of sleep- related breathing disorders (SRBD) were included in the study if, after a first selection night, their central apnea index (CAI) was > 5 or their apnea-hypopnea index (AHI) > 10 and their obstructive apnea index (OAI) < 5. Of 327 screened patients, 14 (4.3%) fulfilled these criteria. Patients were then treated with ACET (250 mg, 1 h before sleep): Polysomnography was repeated once after one single dose (N2) and twice after 1-mo chronic treatment without (N3) and with (N4) additional ACET administration. After each study night, arterial blood gases and chemical drive were measured. CAI (25.5 +/- 6.8 at N1) already decreased during N2 (13.8 +/- 5.2) and further during N3 (6.6 +/- 2.9) and N4 (6.8 +/- 2.8) p < 0.01). OAI remained unchanged. Total sleep time (TST) and sleep efficiency index (SEI) did not change significantly. The number of arousals decreased from 62 +/- 11 at N1 to 40 +/- 5 at N3 (p = 0.019).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. Pevernagie, J. P. Janssens, W. De Backer, M. Elliott, J. Pepperell, and S. Andreas Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Eur. Respir. Rev., December 1, 2007; 16(106): 115 - 124. [Abstract] [Full Text] [PDF]

				S. Javaheri Treatment of obstructive and central sleep apnoea in heart failure: practical options Eur. Respir. Rev., December 1, 2007; 16(106): 183 - 188. [Abstract] [Full Text] [PDF]

				S. Javaheri Acetazolamide Improves Central Sleep Apnea in Heart Failure: A Double-Blind, Prospective Study Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 234 - 237. [Abstract] [Full Text] [PDF]

				J.-P. Richalet, M. Rivera, P. Bouchet, E. Chirinos, I. Onnen, O. Petitjean, A. Bienvenu, F. Lasne, S. Moutereau, and F. Leon-Velarde Acetazolamide: A Treatment for Chronic Mountain Sickness Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1427 - 1433. [Abstract] [Full Text] [PDF]

				M. Wagenaar, P. Vos, Y. Heijdra, L. Teppema, and H. Folgering Comparison of Acetazolamide and Medroxyprogesterone as Respiratory Stimulants in Hypercapnic Patients With COPD Chest, May 1, 2003; 123(5): 1450 - 1459. [Abstract] [Full Text] [PDF]

				R. N. Khayat, A. Xie, A. K. Patel, A. Kaminski, and J. B. Skatrud Cardiorespiratory Effects of Added Dead Space in Patients With Heart Failure and Central Sleep Apnea Chest, May 1, 2003; 123(5): 1551 - 1560. [Abstract] [Full Text] [PDF]

				M. Wagenaar, P. Je Vos, Y.F. Heijdra, L.J. Teppema, and H.T.M. Folgering Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients Eur. Respir. J., November 1, 2002; 20(5): 1130 - 1137. [Abstract] [Full Text] [PDF]

				A. Xie, J. B. Skatrud, D. S. Puleo, P. S. Rahko, and J. A. Dempsey Apnea-Hypopnea Threshold for CO2 in Patients with Congestive Heart Failure Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1245 - 1250. [Abstract] [Full Text] [PDF]

				H. Nakayama, C. A. Smith, J. R. Rodman, J. B. Skatrud, and J. A. Dempsey Effect of Ventilatory Drive on Carbon Dioxide Sensitivity below Eupnea during Sleep Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1251 - 1260. [Abstract] [Full Text] [PDF]

				X. S. Zhou, S. Shahabuddin, B. R. Zahn, M. A. Babcock, and M. S. Badr Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep J Appl Physiol, July 1, 2000; 89(1): 192 - 199. [Abstract] [Full Text] [PDF]

				K.G. van Houwelingen, R. van Uffelen, and A.C.M. van Vliet The sleep apnoea syndromes Eur. Heart J., June 2, 1999; 20(12): 858 - 866. [PDF]

				D. W. HUDGEL and S. THANAKITCHARU Pharmacologic Treatment of Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 691 - 699. [Abstract] [Full Text] [PDF]

				M T Naughton Pathophysiology and treatment of Cheyne-Stokes respiration Thorax, June 1, 1998; 53(6): 514 - 518. [Full Text]